Cargando…

Ethnopharmacokinetic- and Activity-Guided Isolation of a New Antidepressive Compound from Fructus Aurantii Found in the Traditional Chinese Medicine Chaihu-Shugan-San: A New Approach and Its Application

Aims. We aimed to identify an antidepressive compound found in traditional Chinese medicine (TCM) by a new approach called ethnopharmacokinetic- and activity-guided isolation (EAGI). Methods. The new approach targets an unknown chromatographic peak produced by an absorbed compound found in oral Chai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Rong, Huang, Xi, Wang, Yang, Chen, Xiao, Ren, Ping, Ji, Hui, Xie, Ying, Zhang, Yingjin, Huang, Wei, Qiu, Xinjian, Liu, Zhaoqian, Zhou, Honghao, Fan, Lan, Gao, Lichen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291166/ https://www.ncbi.nlm.nih.gov/pubmed/22454671 http://dx.doi.org/10.1155/2012/607584

Ejemplares similares

Antidepressant-like activity of Chaihu-Shugan-San aqueous extract in rats and its possible mechanism
por: Wang, Sue, et al.
Publicado: (2014)

Antidepressant-like effects of Chaihu-Shugan-San via SAPK/JNK signal transduction in rat models of depression
por: Li, Yun-Hui, et al.
Publicado: (2014)

Chaihu-Shugan-San Administration Ameliorates Perimenopausal Anxiety and Depression in Rats
por: Chen, Shujiao, et al.
Publicado: (2013)

SIRT1/FOXO1 Axis-Mediated Hippocampal Angiogenesis is Involved in the Antidepressant Effect of Chaihu Shugan San
por: Zhang, Shan, et al.
Publicado: (2022)

Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex
por: Yan, Lijing, et al.
Publicado: (2020)

Searching the Cytochrome P450 Enzymes for the Metabolism of Meranzin Hydrate: A Prospective Antidepressant Originating from Chaihu-Shugan-San
por: Huang, Xi, et al.
Publicado: (2014)

Simultaneous Determination of Five Components of Chaihu-Shugan-San in Beagle Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study after a Single Dose of Chaihu-Shugan-San
por: Zhu, Yong-liang, et al.
Publicado: (2020)

Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
por: Wu, Jianzhi, et al.
Publicado: (2020)

Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways
por: Liu, Qiong, et al.
Publicado: (2018)

Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
por: Zhang, Shan, et al.
Publicado: (2021)

Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression
por: Qiu, Juan, et al.
Publicado: (2014)

Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San
por: XIE, WEIBIN, et al.
Publicado: (2013)

Potential Molecular Mechanisms of Chaihu-Shugan-San in Treatment of Breast Cancer Based on Network Pharmacology
por: Xiao, Kunmin, et al.
Publicado: (2020)

Effects of Chaihu-Shugan-San for reflux esophagitis: A protocol for systematic review and meta-analysis
por: Zhou, Yan, et al.
Publicado: (2020)

Identification and Comparison of Constituents of Aurantii Fructus and Aurantii Fructus Immaturus by UFLC-DAD-Triple TOF-MS/MS
por: Bai, Yang, et al.
Publicado: (2018)

Exploring mechanisms of Chaihu-Shugan-San against liver fibrosis by integrated multi-omics and network pharmacology approach
por: Xie, Zhihao, et al.
Publicado: (2022)

Reporting quality and risk of bias assessment of animal research on Chaihu-Shugan-San for depression: A systematic review
por: Zhu, Xiao, et al.
Publicado: (2023)

Effects of Chaihu-Shugan-San and Shen-Ling-Bai-Zhu-San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis
por: Yang, Qin-He, et al.
Publicado: (2014)

Effects of Chaihu-Shugan-San capsule for psychogenic erectile dysfunction: Study protocol of a randomized placebo-controlled trial
por: Ren, Feiqiang, et al.
Publicado: (2019)

Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating sphingolipid and glycerinphospholipid metabolism
por: Li, Wei, et al.
Publicado: (2022)

Chaihu Shugan San promotes gastric motility in rats with functional dyspepsia by regulating Drp-1-mediated ICC mitophagy
por: Li, Li, et al.
Publicado: (2023)

Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8
por: Li, Zhiyue, et al.
Publicado: (2023)

Chaihu-shugan-san alleviates depression-like behavior in mice exposed to chronic unpredictable stress by altering the gut microbiota and levels of the bile acids hyocholic acid and 7-ketoDCA
por: Ma, Chong, et al.
Publicado: (2022)

Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress
por: Zhu, Xiaofei, et al.
Publicado: (2022)

Gut Microbiota Is the Key to the Antidepressant Effect of Chaihu-Shu-Gan-San
por: Yu, Meng, et al.
Publicado: (2020)

Effect of Chaihu-Shugan-San on the mRNA expression of the 5-HT1A receptor and cellular proliferation in the hippocampus of epileptic rats with depression
por: YANG, PING, et al.
Publicado: (2016)

Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome
por: He, Zehui, et al.
Publicado: (2019)

Modified Chaihu Shugan Powder for Functional Dyspepsia: Meta-Analysis for Randomized Controlled Trial
por: Yang, Nan, et al.
Publicado: (2013)

Potential Mechanisms Responsible for the Antinephrolithic Effects of an Aqueous Extract of Fructus Aurantii
por: Li, Xiaoran, et al.
Publicado: (2015)

Systematically Deciphering the Pharmacological Mechanism of Fructus Aurantii via Network Pharmacology
por: Jin, Qionglong, et al.
Publicado: (2021)

Development of the Volatile Fingerprint of Qu Aurantii Fructus by HS-GC-IMS
por: Fang, Cuifen, et al.
Publicado: (2022)

A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview
por: Gao, Zu, et al.
Publicado: (2022)

Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway
por: Liang, Yinji, et al.
Publicado: (2018)

Pharmacokinetic Study of 7 Compounds Following Oral Administration of Fructus Aurantii to Depressive Rats
por: Zhang, Xianhua, et al.
Publicado: (2018)

Role of Quzhou Fructus Aurantii Extract in Preventing and Treating Acute Lung Injury and Inflammation
por: Li, Lili, et al.
Publicado: (2018)

Network pharmacology and experimental studies for deciphering the molecular targets and mechanisms of Chaihu Shugan powder in the treatment of functional dyspepsia
por: Wang, Yujiao, et al.
Publicado: (2023)

The Effects of Low-Dose and High-Dose Decoctions of Fructus aurantii in a Rat Model of Functional Dyspepsia
por: Zhu, Jing, et al.
Publicado: (2020)

Drying kinetics and attributes of fructus aurantii processed by hot air thin-layer drying at different temperatures
por: Bai, Tingting, et al.
Publicado: (2023)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
por: Lei, Sisi, et al.
Publicado: (2022)

Chaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiota
por: Han, Sang-Kap, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ce2r7an98clbkk46f86hou5lc4